Ipilimumab and Radiation in Patients with High Risk Resected or Regionally Advanced Melanoma. Salama AKS, Palta M, Rushing CN, Selim MA, et al. Clin Cancer Res 2020 Nov 10. pii: 1078-0432.CCR-20-2452.

Read + Share

Amedeo Smart

Independent Medical Education

Salama AKS, Palta M, Rushing CN, Selim MA, et al. Ipilimumab and Radiation in Patients with High Risk Resected or Regionally Advanced Melanoma. Clin Cancer Res 2020 Nov 10. pii: 1078-0432.CCR-20-2452.
PMID: 33172894